Relative efficacy of antibody-drug conjugates and other anti-HER2 treatments on survival in HER2-positive advanced breast cancer: a systematic review and meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12885-024-12478-1
Published Online: 2024-06-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kang, Zian
Jin, Yuqing
Yu, Huihui
Li, Su
Qi, Yingjie
Text and Data Mining valid from 2024-06-08
Version of Record valid from 2024-06-08
Article History
Received: 29 November 2023
Accepted: 4 June 2024
First Online: 8 June 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.